title: [Not Available].
abstract: Summary A cross-sectional study led in Bamako analyzed the seroprevalence of hepatitis C virus (HCV) and its genotypes among 91 patients carrying chronic liver diseases at the stage of cirrhosis (53) or hepato cellular carcinoma (38) and, on comparative basis in 92 blood donors as control population. False serologic reactions were found with ELISA (3/91 either 3,3% of the liver diseases and 1/92 or 1,1% of the control). Positive tests by ELISA confirmed by a RIBA test were finally considered. Concerning all the liver diseases, the seroprevalence of HCV was 15,4% including 15,1% in cirrhosis, 21% in hepatocellular carcinoma patients versus 2,2% in blood donors. The HBs antigen was associated in 5,6% of the cases In the hepatite C population, genotype 2a/2c was definitely prevalent, about 85,7%. Thus the role of the HCV in genesis of cirrhosis and hepatocellular carcinoma in Mali, appears significant.
authors.forename: A
authors.initials: A
authors.lastname: Konate
authors.forename: M
authors.initials: M
authors.lastname: Diarra
authors.forename: D
authors.initials: D
authors.lastname: Minta
authors.forename: M
authors.initials: M
authors.lastname: Dembele
authors.forename: I
authors.initials: I
authors.lastname: Maiga
authors.forename: D
authors.initials: D
authors.lastname: Sangare
authors.forename: S
authors.initials: S
authors.lastname: Maiga
authors.forename: Ha
authors.initials: H
authors.lastname: Traore
authors.forename: My
authors.initials: M
authors.lastname: Maiga
authors.forename: C
authors.initials: C
authors.lastname: Payan
authors.forename: F
authors.initials: F
authors.lastname: Lunel
authors.forename: B
authors.initials: B
authors.lastname: Carbonnelle
authors.forename: P
authors.initials: P
authors.lastname: Cales